Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research
In Their Words

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993


Proeschold-Bell, RJ, Evon, DM, Makarushka, C, Wong, JB, Datta, SK, Yao, J, Patkar, AA, Mannelli, P, Hodge, T, Naggie, S, Wilder, JM, Fried, MW, Niedzwiecki, D, and Muir, AJ. "The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial." Contemporary Clinical Trials 72 (July 10, 2018): 73-85.

Full Text

Younossi, ZM, Afendy, A, Stepanova, M, Racila, A, Nader, F, Gomel, R, Safer, R, Lenderking, WR, Skalicky, A, Kleinman, L, Myers, RP, Subramanian, GM, McHutchison, JG, Levy, C, Bowlus, CL, Kowdley, K, and Muir, AJ. "Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO." July 2018.

Full Text

Nitsche, B, Miller, SC, Giorgio, M, Berry, CA, and Muir, A. "Improving Hepatitis C Identification: Technology Alone Is Not the Answer." Health Promotion Practice 19, no. 4 (July 2018): 506-512.

Full Text

Patel, YA, and Muir, AJ. "Editorial: platelet transfusions in cirrhosis-do the risks outweigh the unclear benefits?." Alimentary Pharmacology & Therapeutics 47, no. 11 (June 2018): 1553-1554.

Full Text

Wilder, JM, and Muir, A. "Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations." Expert Opinion on Pharmacotherapy 19, no. 5 (March 24, 2018): 451-456. (Review)

Full Text

Jou, JH, and Muir, AJ. "Hepatocellular Carcinoma Surveillance." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 16, no. 1 (January 2018): 19-20.

Full Text

Tana, MM, and Muir, AJ. "Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 16, no. 1 (January 2018): 16-18.

Full Text

Collins, LF, Chan, A, Zheng, J, Chow, S-C, Wilder, JM, Muir, AJ, and Naggie, S. "Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection." Open forum infectious diseases 5, no. 1 (January 2018): ofx264-.

Full Text

Henson, JB, Patel, YA, Wilder, JM, Zheng, J, Chow, S-C, King, LY, and Muir, AJ. "Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis." Digestive diseases and sciences 62, no. 11 (November 2017): 3200-3209.

Full Text

Sofue, K, Burke, LMB, Nilmini, V, Alagiyawanna, M, Muir, AJ, Choudhury, KR, Jaffe, TA, Semelka, RC, and Bashir, MR. "Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5." Journal of magnetic resonance imaging : JMRI 46, no. 3 (September 2017): 783-792.

Full Text